7498 Results (Page 230 of 300)
Pharmaceuticals Markets Research Reports
Malaysia Oncology Drugs Market Analysis
By 2030, it is anticipated that the Malaysia oncology drugs market will reach a value of $xx Mn from $315.83 Mn in 2022, growing at a CAGR of xx% during 2022-30. The oncology drugs market in Malaysia is dominated by a few domestic pharmaceutical companies such as Pharmaniaga Berhad, Biocon Sdn Bhd, and Duopharma Biotech. The oncology market in Malaysia is segmented into different therapeutic areas and different treatment types. The major factors affecting the Malaysia oncology drugs market are the increasing disease burden of non-communicable diseases like cancer and the lack of healthcare facilities for cancer treatment in most areas of Malaysia.
Japan Retail Pharmacy Market Analysis
Japan's Retail pharmacy market is projected to grow from $64.56 Bn in 2022 to $114.28 Bn by 2030, registering a CAGR of 7.4% during the forecast period of 2022-2030. The growing demand for convenience in healthcare is driving the retail pharmacy market as more people are looking for ways to easily access and manage their medications. The retail pharmacy market in Japan is highly competitive, with several large players dominating the market, including Matsumoto Kiyoshi Holdings Co., Ltd, Aeon Co., Ltd, and Lawson, Inc.
Germany Dialysis Market Analysis
Germany's dialysis market is projected to grow from $1.395 Bn in 2022 to $2.581 Bn by 2030, registering a CAGR of 8% during the forecast period of 2022-2030. One of the main reasons propelling market growth in Europe is the expanding elderly population. In 2020, 91% of the dialysis market in Europe was accounted for by the hemodialysis segment. Due to its increased dialysis efficacy, patients choose hemodialysis (HD). Additionally, the emergence of less complicated hemodialysis machines has made home hemodialysis easy. With the right training and assistance from a friend or family member, one may be able to perform hemodialysis at home.
China Dermatology Drugs Market Analysis
By 2030, it is anticipated that the China Dermatology drugs market will reach a value of $3.46 Bn from $1.37 Bn in 2022, growing at a CAGR of 12.3% during 2022-2030. The dermatology drug market in China is dominated by a few large pharmaceutical companies such as Johnson and Johnson Shanghai, China Resources Pharmaceutical Group and Chongqing Huapont Pharm. The dermatology drug market in China is segmented by drug class, drug type, prescription mode, indication, route of administration, end-user, and distribution channel. The major factors affecting the China dermatology drugs market are the increasing disease burden of non-communicable diseases like cancer and the lack of healthcare facilities for cancer treatment in most areas of China.
Vietnam Pharmaceutical Market Analysis
This report presents a strategic analysis of the Vietnam Pharmaceutical Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Vietnam Pharmaceutical Market, offering unmatched value, accuracy and expert insights.
Philippines Oncology Therapeutics Market Analysis
By 2030, it is anticipated that the Philippines Oncology Therapeutics Market will reach a value of $790 Mn from $400 Mn in 2022, growing at a CAGR of 8.9% during 2022-2030. The Oncology Therapeutics Market in the Philippines is dominated by a few domestic pharmaceutical companies such as Pascual Laboratories, TGP Group, and United Laboratories. The Oncology Therapeutics Market in the Philippines is segmented into different types of cancer and different therapy type. The major risk factors associated with cancer are diet, alcohol, tobacco, air pollution, and physical inactivity. The demand for Philippines Oncology Therapeutics is increasing on account of the rise in initiatives taken by the Government of the country.
UAE Dialysis Market Analysis
The UAE Dialysis Market is projected to grow from $0.581 Bn in 2022 to $1.036 Bn by 2030, registering a CAGR of 7.5% during the forecast period of 2022-2030. The increasing awareness about the importance of kidney health and the availability of treatments is also expected to drive the growth of the dialysis market in the UAE. Fresenius Medical Care is one of the leading providers of dialysis products and services in the UAE, with a significant presence in the market.
Global Retail Pharmacy Market Analysis
This report presents a strategic analysis of the Global Retail Pharmacy Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Global Retail Pharmacy Market, offering unmatched value, accuracy and expert insights.
India Gastrointestinal Drugs Market Analysis
This report presents a strategic analysis of the India Gastrointestinal Drugs Market Analysis and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the India Gastrointestinal Drugs Market Analysis, offering unmatched value, accuracy, and expert insights.
Spain Retail Pharmacy Market Analysis
Spain's retail pharmacy market is projected to grow from $20.05 Bn in 2022 to $31.70 Bn by 2030, registering a CAGR of 5.9% during the forecast period of 2022-2030. The retail pharmacy market in Spain is a well-established market, with over 24,000 pharmacies operating in the country. Farmacias Ahorro is a top retail pharmacy chain in Spain with more than 1,000 stores in the country.
Brazil Oncology Drugs Market Analysis
By 2030, it is anticipated that the Brazil oncology drugs market will reach a value of $12.7 Bn from $4.9 Bn in 2022, growing at a CAGR of 12.6% during 2022-2030. The oncology drug market in Brazil is dominated by a few large pharmaceutical companies such as EMS Pharma, Eurofarma, and Takeda Pharma. The oncology market in Brazil is segmented by different therapeutic areas and by different treatment types. The major factors affecting the Brazilian oncology drugs market are the high cost of the drugs, and the structured reimbursement system for the treatment.
Vietnam Oncology Therapeutics Market Analysis
By 2030, it is anticipated that the Vietnam Oncology Therapeutics Market will reach a value of $1.8 Bn from $0.91 Bn in 2022, growing at a CAGR of 8.6% during 2022-2030. The Oncology Therapeutics Market in Vietnam is dominated by a few domestic pharmaceutical companies such as Hau Giang Pharmaceutical, Vietnam Pharma, and Pymepharco. The Oncology Therapeutics Market in Vietnam is segmented into different types of cancer and different therapy type. The major risk factors associated with cancer are diet, alcohol, tobacco, air pollution, and physical inactivity. The demand for Vietnam Oncology Therapeutics is increasing on account of the rise in initiatives taken by the Government of the country.
Thailand Pharmaceutical Market Analysis
This report presents a strategic analysis of the Thailand Pharmaceutical Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Thailand Pharmaceutical Market, offering unmatched value, accuracy and expert insights.
Romania Pharmaceutical Market Analysis
This report presents a strategic analysis of the Romania Pharmaceutical Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Romania Pharmaceutical Market, offering unmatched value, accuracy and expert insights.
India Retail Pharmacy Market Analysis
India's retail pharmacy market is projected to grow from $18.89 Bn in 2022 to $40.19 Bn by 2030, registering a CAGR of 9.9% during the forecast period of 2022-2030. India's economic growth also contributes to market growth, as a growing economy leads to increased disposable income and investment in healthcare services. The retail pharmacy market in India is highly competitive, with several large players dominating the market, including Apollo Pharmacy, Medplus, and Healthkart.
Malaysia Retail Pharmacy Market Analysis
This report presents a strategic analysis of the Malaysia retail pharmacy market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Malaysia Retail Pharmacy Market, offering unmatched value, accuracy and expert insights.
Malaysia Pharmaceutical Market Analysis
This report presents a strategic analysis of the Malaysia pharmaceutical market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Malaysia Pharmaceutical Market, offering unmatched value, accuracy and expert insights.
India Women's Health Market Analysis
India's women’s health market is projected to grow from $0.726 Bn in 2022 to $1.325 Bn by 2030, registering a CAGR of 7.80% during the forecast period of 2022-2030. The increasing number of working women in India is driving the women's health market as they have more disposable income and need health care services. Some key players in the India Women's Health market include Apollo Hospitals, Manipal, and Medanta.
Nigeria Radiotherapy Market Analysis
By 2030, it is anticipated that the Nigeria Radiotherapy Market will reach a value of $xx Mn from $6 Mn in 2022, growing at a CAGR of xx% during 2022-2030. The Radiotherapy Therapeutics Market in Nigeria is dominated by a few domestic players such as Accuray, Varian Medical Systems, and Siemens. The radiotherapy market in Nigeria is segmented into different types, technology, procedures, application, and end-user. The significant risk factors associated with awareness of radiotherapy shortage of skilled staff, government initiatives and reimbursement policy. The demand for Nigeria Radiotherapy is increasing due to the rise in cancer cases in the country.
Spain Biosimilars Market Analysis
Spain's biosimilars market size was valued at $0.4 Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 21.1% from 2022 to 2030 and will reach $1.7 Bn in 2030. The market is segmented by product type and indication type. The Spainn Biosimilars market will grow as there is a shortage of qualified radiologists and imaging technologists in some areas, leading to longer wait times and delays in diagnosis and treatment. The key market players are Pfizer (USA), Roche (CHE), Novartis (CHE), Merck (USA), Sanofi (FRA), GlaxoSmithKline (GBR), AstraZeneca (GBR), and others.
Brazil Biosimilars Market Analysis
Brazil's biosimilars market size was valued at $0.4 Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 23.2% from 2022 to 2030 and will reach $2.5 Bn in 2030. The market is segmented by product type and indication type. The Brazil Biosimilars market will grow with The increased incidence of chronic illnesses, rising healthcare expenses, and the demand for affordable biologic medicine substitutes. The key market players are Roche (CHE), Novartis (CHE), Pfizer (USA), Sanofi (FRA), Merck (USA), and others.
Australia Biosimilars Market Analysis
Australia biosimilars market size was valued at $230 Mn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 23.7% from 2022 to 2030 and will reach $1263 Mn in 2030. The market is segmented by product type and indication type. The Australian Biosimilars market will grow as there is a shortage of qualified radiologists and imaging technologists in some areas, leading to longer wait times and delays in diagnosis and treatment. The key market players are Sonic Healthcare Limited Amgen, Biocon, Celltrion Healthcare, Dr. Reddy's Laboratories, and others.
Australia Women's Health Market Analysis
Australia women’s health market is projected to grow from $479 Mn in 2022 to $781 Mn by 2030, registering a CAGR of 6.30% during the forecast period of 2022-30. The Australian government has implemented a number of policies and programs aimed at promoting women's health, such as providing funding for cancer screenings and research on women's health issues through the Medicare Benefits Schedule (MBS). Companies such as Pfizer, AstraZeneca, and GlaxoSmithKline are major players in the Australia women's health market, producing drugs and supplements for conditions such as osteoporosis and menopause.
France Oncology Therapeutics Market Analysis
By 2030, it is anticipated that the France Oncology Therapeutics Market will reach a value of $8.8 Bn from $4.9 Bn in 2022, growing at a CAGR of 7.4% during 2022-2030. The Oncology Therapeutics Market in France is dominated by a few domestic pharmaceutical companies such as Bristol Myers Squibb, Boehringer Ingelheim, and CureVac. The Oncology Therapeutics Market in France is segmented into different types of cancer and different therapy type. The major risk factors associated with cancer are diet, alcohol, tobacco, air pollution, and physical inactivity. The demand for France Oncology Therapeutics is increasing on account of the rise in initiatives taken by the Government of the country.
China Oncology Therapeutics Market Analysis
By 2030, it is anticipated that the China Oncology Therapeutics Market will reach a value of $31.1 Bn from $14.6 Bn in 2022, growing at a CAGR of 9.9% during 2022-2030. The Oncology Therapeutics Market in China is dominated by a few domestic pharmaceutical companies such as Bristol Myers Squibb, Boehringer Ingelheim, and CureVac. The Oncology Therapeutics Market in China is segmented into different types of cancer and different therapy type. The major risk factors associated with cancer are diet, alcohol, tobacco, air pollution, and physical inactivity. The demand for China Oncology Therapeutics is increasing on account of the rise in initiatives taken by the Government of the country.
